Pharmaceutical isolator companies specialize in the design, manufacture, and supply of containment solutions for the pharmaceutical and biotechnology industries. Isolators are critical components of pharmaceutical manufacturing and research, providing a controlled and sterile environment for handling and processing highly sensitive materials and substances.
*Disclaimer: List of key companies in no particular orderLatest Pharmaceutical isolator Companies Update
Skan AG
Azbil Telstar s.l.u
Cytiva
NuAire Inc
Schematic Engineering Industries
MBraun GMBH
Fedegari Autoclavi S.p.A
Hosokawa Micron B.V
Syntegon Technology
Isotech Design
Getinge AB
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for pharmaceutical isolator is being driven by the rising sterilized procedures. Several factors, including an increase in R&D facilities, the rising cost of noncompliance, and the increased usage of hazardous substances, drive the pharmaceutical isolator market. Because the inside of the pharmaceutical isolator is segregated from the outside world, commonly used pharmaceuticals, quality control operations, and items are also isolated. Currently, the bulk of pharmaceutical isolators is designed specifically for the demands of research and manufacturing organizations. The key drivers of market expansion are cheaper operation and procurement costs than typical clean rooms. Because pharmaceutical isolators ensure sterility, improved mobility, and coherence in active pharmaceutical ingredient (API) manufacture, organizations can acquire drug safety regulatory clearances more easily. During the projected period, major factors such as increased sterility assurance of pharmaceutical isolators are expected to fuel market growth. The high sterility assurance of pharmaceutical isolators drives up market demand. The pharmaceutical production process includes incorporating active pharmaceutical chemicals with great potency, necessitating utmost caution and sterile settings to prevent contamination.
Furthermore, according to an Inos article titled 'Benefits of Aseptic Isolators' published in May 2020, positive pressure is maintained in the isolator to ensure that particles from the setup room do not enter the isolator and contamination does not occur. Aseptic isolators are commonly encountered in the pharmaceutical industry and are widely utilized for sterile injectable drug filling and sterile & pharmacy drug compounding. Thus, driving the Pharmaceutical Isolator market revenue.
The Pharmaceutical Isolator market segmentation, based on type, includes open isolator and closed isolator. The open isolator segment dominated the market, accounting for 35% of market revenue. Open isolator systems provide continuous or semi-continuous material ingress and egress during operations through one or more apertures. These holes are developed and validated to prevent contaminant transmission by always preserving the pressure differential.
February 2023: Cytiva (US) bought Vanrx Pharmasystems (Canada), a Canadian firm that manufactures robotic aseptic filling equipment that fills vials, syringes, and cartridges with less risk and faster patient delivery. Due to this strategy, Cytiva purchased Vanrx's flagship products, including the Microcell Vial Filler and the SA25 Aseptic Filling Work cell. These devices can use robotics to automate aseptic filling within closed and gloveless isolators.
Based on product type, the Pharmaceutical Isolator market segmentation includes sterility test isolators, process isolators, and decontamination pass boxes. The sterility test isolator dominated the market, accounting for 35% of market revenue. This is due to the sterility test isolators, which allow operators to perform sterility testing in an aseptic atmosphere, ensuring the procedure's integrity. They also provide controlled loading and unloading of processed products and waste materials into the isolator enclosure.
Based on product class, the Pharmaceutical Isolator market segmentation includes ISO Class 3 and ISO Class 5. The ISO Class 5 segment dominated the market. This is because ISO cleanliness requirements are based on particle levels within a certain room and are measured based on the size and number of particles per air volume.
Figure 1: Pharmaceutical Isolator Market, by Product Class, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Based on application, the Pharmaceutical Isolator market segmentation includes sterility testing, sampling/ weighing/distribution, animal laboratories, aseptic tissue handling/microbiology testing/pathogenic sampling, defiltration and drying, and others, The sterility testing segment dominated the market. Sterility testing is a Good Manufacturing Practice (GMP). Before release and patient administration, microbiological testing is required to confirm that the sterile items do not contain live microorganisms.
Based on End users, the Pharmaceutical Isolator market segmentation includes biopharma/cell & gene therapy companies, academic & research institutes, hospitals, and and contract research organization & contract manufacturing organization. The biopharma/cell & gene therapy companies category generated the most income. This is due to the rising use of isolators in numerous industries and stringent regulatory agencies to ensure medicine safety and efficacy.
By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American Pharmaceutical Isolator market area will dominate this market; This is due to the region's improved healthcare infrastructure, increased demand for pharmaceutical isolators, low operational costs, and the existence of a large number of market competitors. Furthermore, greater use of sterilized procedures connected to pharmaceutical isolators helps to drive regional market expansion.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: Pharmaceutical Isolator Market Share By Region 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Pharmaceutical Isolator market accounts for the second-largest market share because of an increase in pharmaceutical isolator demand from the pharmaceutical and biotechnology industries, excellent sterility assurance, and low operational expenses. Further, the German Pharmaceutical Isolator market held the largest market share, and the UK Pharmaceutical Isolator market was the fastest growing market in the European region
The Asia-Pacific Pharmaceutical Isolator Market is expected to grow at the fastest CAGR from 2024 to 2032. This is due to rising healthcare costs and increased use of sterilised procedures. Moreover, China’s Pharmaceutical Isolator market held the largest market share, and the Indian Pharmaceutical Isolator market was the fastest growing market in the Asia-Pacific region.
Pharmaceutical Isolator Key Market Players & Competitive Insights
Leading market companies are extensively spending R&D on increasing their product lines, which will help the Pharmaceutical Isolator market grow even more. Important market developments include new product releases, contractual agreements, acquisitions and mergers, greater investments, and collaboration with other organizations. The Pharmaceutical Isolator industry must produce cost-effective merchandise to flourish and thrive in a more competitive and increasing market climate.
Manufacturing locally to reduce operating costs is an effective business strategy manufacturers use in the worldwide Pharmaceutical Isolator industry to serve clients and expand the market sector. The Pharmaceutical Isolator industry has provided some of the most important benefits recently. Major players in the Pharmaceutical Isolator market, including Skan AG, Cytiva, NuAire Inc and others, are attempting to increase market demand by investing in research and development operations.
BICO (previously CELLINK) is the world's top bio convergence firm. We help our customers to improve people's health and lives by mixing various technologies such as artificial intelligence, robots, computer science, and 3D bioprinting with biology. The firm is focused on developing technologies that will enable tissue engineering,multiomics, diagnostics, and cell line development in Health 4.0 Next Generation Core Industry Ecosystems. In December 2021, BICO struck a two-year distribution agreement with Applitech pharmaceutical equipment innovation to market its single-cell isolators in China. Almost 100 of the company's single-cell isolators will be sold in the agreement for more than USD 10 million.
ILC Dover is a pioneer in the innovative design and manufacture of solutions for the biopharmaceutical, pharmaceutical, and medical device markets and a key supplier to the (aero)space industries. Their customers will attest to their unwavering commitment to high-value products, advanced technology, and responsive service, as their visionary solutions have improved efficiency while protecting people, products, and infrastructure in hazardous conditions since 1947. The soloPURE flexible aseptic isolator, a low-cost, closed-barrier solution for sterile manufacturing, was introduced by ILC Dover LP. soloPURE symbolizes the future of sterile manufacturing, with a fully disposable, single-use chamber and a CAPEX-efficient compact design.
Key Companies in the Pharmaceutical Isolator market include
Pharmaceutical Isolator Industry Developments
June 2022:Jacomex Equipment formed a marketing cooperation with Medical Supply Company (MSC). MSC has many years of market experience with field teams closest to consumers, and the company's commercial team, now working abroad, had the pleasure of welcoming Cian Murphy and finalizing the deal between Jacomex and MSC. The start of a long and fruitful partnership. This has assisted the corporation in expanding its operations.
January 2022:Clario collaborated with XingImaging, a radiopharmaceutical manufacturing and positron emission tomography (PET) acquisition company, to provide PET imaging clinical trials in China for testing innovative treatments. Clario and XingImaging have agreed to share their combined resources and neuroscience specialists to accelerate the initiation of clinical studies and medication discovery in China.
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
Pharmaceutical Isolator Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)